Mylan UK informs MHRA of crystalline precipitate in antipsychotic medicine
The UK’s MHRA issues a drug alert regarding aripiprazole oral solution, but no recall is issued due to concerns over supply.
Archives for March 13, 2020
US FDA details problems that led to Biocon’s Form 483
The published Form 483 details five points of concern raised by inspectors to the company’s API facility in India.
New York opioid trial delayed due to coronavirus
A trial against multiple opioid manufacturers and distributors, previously set to begin next week, gets postponed due to the coronavirus spread.